Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030

"Innovations in Antibody-Based Probes, AI-Enhanced Platforms, and Targeted Radiotracers Drive a New Era of Precision and Non-Invasive Diagnostics"

Boston, Oct. 30, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Biological and Medical Imaging Reagents: Global Markets” is projected to grow from $26.6 billion in 2025 to $40.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

This report provides an overview of the global market for biological and medical imaging reagents, analyzing trends, and technologies that shape the industry. It segments the market by type, modality, technology, application, end user, and region, covering major countries across North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also examines the competitive landscape, ranking leading companies and offering in-depth profiles, while highlighting patents and emerging innovations.

This report is especially relevant now due to the favorable timing in the global healthcare landscape. With a growing emphasis on preventive diagnostics and real-time disease monitoring, the demand for advanced imaging reagents is accelerating. The integration of AI into medical imaging and the progress of several next-generation reagents, many in late-stage trials or recently approved, signal a transformative phase for the industry. Over the next few years, there is a strong opportunity for investment, innovation, and widespread clinical adoption, making this a critical moment for stakeholders in the market.

The factors driving the market’s growth include:

More R&D Funding: Increased investment in research is driving innovation in imaging reagents, leading to safer, more effective tools for diagnostics and treatment monitoring.

Rise in Chronic Diseases: As conditions like cancer and heart disease become more common, the need for advanced imaging to diagnose and manage these illnesses is growing rapidly.

Growth of Personalized Medicine: Theranostics and tailored treatments rely on precise imaging. Specialized reagents help detect disease markers and track how well therapies are working.

Request a sample copy of the global market for biological and medical imaging reagents report.

Report Synopsis

Interesting fact:

• AI is revolutionizing how imaging reagents are used, enabling faster, more accurate interpretation of diagnostic images. There has been a surge in clinical trials and product launches focused on next-generation biologic imaging reagents, especially for cancer diagnostics. These agents are designed to provide higher specificity, reduced invasiveness, and improved patient outcomes.

The report addresses the following questions:

1. What are the projected market size and growth rate?

• The global market for biologics and medical imaging reagents was $24.6 billion in 2024. The market is expected to grow at a CAGR of 8.6%, reaching about $40.1 billion by the end of 2030.

2. What factors are driving the growth of the market?

• Factors driving the biologic and medical imaging reagents market include increasing R&D investments, growing prevalence of chronic diseases, rising adoption of theranostics and personalized medicine, and replacing toxic reagents with safer alternatives.

3. What are the key challenges and opportunities of the market?

• The challenges include complex regulatory approvals, high development costs, limited reimbursement policies, and the need for specialized handling and safety protocols, especially for radioactive or nanoparticle-based agents. Opportunities exist in the form of rising prevalence of chronic diseases, growing demand for personalized diagnostics, and rapid advances in technologies like AI, radiopharmaceuticals, and multimodal imaging.

4. Which market segments are covered in the report?

• The market is segmented based on type, modality, technology, application, end-use, and region. Types include contrast reagents, radioactive reagents, and optical reagents. Imaging modalities include optical imaging reagents, X-ray/CT imaging reagents, nuclear imaging reagents, MRI imaging reagents, multimodal imaging reagents, and ultrasound imaging reagents. Technology segments include quantum dots, radiopharmaceuticals, fluorescent proteins, fluorescent dyes and probes, and nanoparticles.
• The market is also categorized by application into in vivo and in vitro uses. By end-use, the reagents are segmented into diagnostics and R&D, supporting both clinical and scientific advances. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World. North America includes the U.S., Canada, and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, and the Rest of Asia-Pacific.

5. Which type will be dominant through 2030?

• Contrast reagents will dominate the market through the end of 2030.

6. Which region has the largest market share?

• North America accounted for 42.5% of the market in 2024.

Market leaders include:

• AGILENT TECHNOLOGIES INC.
• ALTONA DIAGNOSTICS GMBH
• ANALYTIK JENA GMBH+CO. KG.
• BAYER AG
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• GE HEALTHCAR
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.

Related reports:

Global Markets for Media, Sera and Reagents in Biotechnology: This report offers a detailed overview of the market for media, sera, and reagents in biotechnology, examining current trends and future growth potential. It explores market drivers, challenges, and opportunities, and provides insights into emerging technologies, patent activity, ESG developments, and investment trends. The market is segmented by product type, end user, and region, with in-depth analysis of reagents, media, and sera. It also includes profiles of key companies, making it a valuable resource for understanding the evolving global biotech landscape.

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, contact info@bccresearch.com.    

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

BCC Research

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, U.S.
Email: info@bccresearch.com
Phone: +1 781-489-7301

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.